Two novel genes from psoriatic epidermis: psoriastatin type I and psoriastatin type II
US6818214B2 · kind B2 · utility
1Cited by
0References
9Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 16, 1996 |
| Grant date | Nov 16, 2004 |
| Priority date | — |
| Expiry date | Oct 16, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA01K2217/075
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of modulating cell proliferation or apoptosis comprising modulating psoriastatin activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.